Dr. Shureiqi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
Ann Arbor, MI 48109Phone+1 734-936-4000
Education & Training
University of MichiganFellowship, Hematology and Medical Oncology, 1994 - 1997
University at BuffaloFellowship, Hematology and Medical Oncology, 1991 - 1992- University at BuffaloResidency, Internal Medicine, 1989 - 1991
Damascus University Faculty of MedicineClass of 1985
Certifications & Licensure
TX State Medical License 1999 - 2026
MI State Medical License 1990 - 2025
OK State Medical License 2020 - 2021
WV State Medical License 1992 - 1995- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Molecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal Cancers Start of enrollment: 2003 Aug 20
Publications & Presentations
PubMed
- 183 citationsThe 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-δ to induce apoptosis in colorectal cancer cellsImad Shureiqi, Wei Jiang, Xiangsheng Zuo, Yuanqing Wu, Julie B. Stimmel
Proceedings of the National Academy of Sciences of the United States of America. 2003-08-19 - 36 citationsEffects of Gut-Targeted 15-LOX-1 Transgene Expression on Colonic Tumorigenesis in MiceXiangsheng Zuo, Zhanglong Peng, Yuanqing Wu, Micheline J. Moussalli, Xiu L. Yang
Journal of the National Cancer Institute. 2012-05-02 - 72 citationsThe critical role of 15-lipoxygenase-1 in colorectal epithelial cell terminal differentiation and tumorigenesis.Imad Shureiqi, Yuanqing Wu, Dongning Chen, Xiu L. Yang, Baoxiang Guan
Cancer Research. 2005-12-15
Press Mentions
Science Reveals That This Type of Diet Can Increase Your Risk of Pancreatic CancerJuly 30th, 2022
Colorectal Cancer Survivor Turns to Clinical Trial for Neuropathy ReliefOctober 30th, 2018- Throat Cancer Survivor Now Singing MD Anderson’s PraisesSeptember 25th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
